跳至主要内容
临床试验/NL-OMON54917
NL-OMON54917已完成不适用

A randomised controlled pilot trial investigating the feasibility of monitoring patients with or at risk for cardiovascular disease who have symptoms suspected of COVID-19 by pulse oximetry at home - CovidSat@Home

niversitair Medisch Centrum Utrecht0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) Age *40 years
  • 2) Cardiovasculair risk profile or cardiovascular disease (overweight,
  • hypertension, diabetes, smoking, coronary artery disease, previous myocardial
  • infarction, heart failure)
  • 3) Presumably COVID-19 (both SARS-CoV-2 positive and non-COVID-19 confirmed
  • 4) Moderate-severe symptoms
  • 5) Mentally competent

排除标准

  • 1) Severe illness requiring hospital admission
  • 2) Patient does not want future hospitalisation
  • 3) Known anemia
  • 4) Inadequate mastery of the Dutch language
  • 5) Not willing to sign informed consent
  • 6) Not willing to adhere to study procedures

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验

A randomised controlled pilot trial investigating... | 临床试验